Inventor · disambiguated record
Kerren Kalai Swinger
Also filed as: SWINGER KERREN K · SWINGER KERREN KALAI
14 granted patents·11 pending applications·74 citations·filing 2014–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0197US11014913B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Granted May 25, 2021·6 cites·13 claims
- 0297US10550105B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·13 cites·8 claims
- 0396US9598374B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Mar 21, 2017·25 cites·9 claims
- 0495US11566020B1Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2021·Granted Jan 31, 2023·3 cites·26 claims
- 0594US10870641B2Pyridazinones as PARP7 inhibitorsRIBON THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·6 cites·30 claims
- 0693US10081603B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Sep 25, 2018·9 cites·27 claims
- 0792US10562891B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·5 cites·4 claims
- 0889US11293927B2Screening methods for PARP modulatorsRIBON THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·3 cites·14 claims
- 0987US10800743B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2018·Granted Oct 13, 2020·2 cites·20 claims
- 1086US2025034120A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1185US2024182426A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2023·Application pending·0 cites
- 1282US12371421B2Solid forms of a PARP7 inhibitorRIBON THERAPEUTICS INC·Filed 2020·Granted Jul 29, 2025·1 cites·20 claims
- 1382US11008308B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Granted May 18, 2021·1 cites·2 claims
- 1482US2025020654A1Screening methods for parp modulatorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1580US2023192664A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1674US11512053B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2020·Granted Nov 29, 2022·0 cites·20 claims
- 1773US2022206008A1Screening methods for parp modulatorsRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1868US11958837B2Quinazolinones as PARP14 inhibitorsRIBON THERAPEUTICS INC·Filed 2021·Granted Apr 16, 2024·0 cites·46 claims
- 1961US2023303542A1Solid forms of a parp14 inhibitorRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2059US2022265655A1Methods of treating inflammatory diseasesRIBON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2152US2019077795A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2018·Application pending·0 cites
- 2250US2022388985A1Targeted protein degradation of parp14 for use in therapyRIBON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2343US2017283400A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Application pending·0 cites
- 2436US2017291905A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Application pending·0 cites
- 2533US9777020B2Furo-3-carboxamide derivatives and methods of useABBVIE INC·Filed 2015·Granted Oct 3, 2017·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Kerren Kalai Swinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →